Circulation, Vol 78, 539-545, Copyright © 1988 by American Heart Association
E Barrett-Connor and KT Khaw
Plasma obtained and frozen in 1972-1974 from 1,009 white men (40-79 years
old) who have been followed for 12 years was examined for endogenous sex
hormone levels according to prevalent or subsequent cardiovascular disease.
In these older men, no sex hormone measured (testosterone, androstenedione,
estrone, or estradiol) was significantly associated with known
cardiovascular disease at baseline or with subsequent cardiovascular
mortality or ischemic heart disease morbidity or mortality. Sex
hormone-binding globulin levels were also similar by disease status.
Analyses of hormone:sex hormone-binding globulin ratios or of
estrogen:androgen ratios showed a similar lack of association with
cardiovascular disease. Testosterone levels were significantly inversely
associated with levels of blood pressure, fasting plasma glucose, and
triglyceride and body mass index. In contrast, the only significant
estrogen risk factor associations were positive correlations of estrone
with total plasma cholesterol, triglyceride, and glucose. These data do not
support a causal role for elevated endogenous estrogen levels and heart
disease.
ARTICLES
Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study
University of California, San Diego, Department of Community and Family Medicine, La Jolla 92093.
This article has been cited by other articles:
 |
|
 |
|
  K.-T. Khaw, M. Dowsett, E. Folkerd, S. Bingham, N. Wareham, R. Luben, A. Welch, and N. Day Endogenous Testosterone and Mortality Due to All Causes, Cardiovascular Disease, and Cancer in Men: European Prospective Investigation Into Cancer in Norfolk (EPIC-Norfolk) Prospective Population Study Circulation, December 4, 2007; 116(23): 2694 - 2701. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Nettleship, T. H. Jones, K. S. Channer, and R. D. Jones Physiological Testosterone Replacement Therapy Attenuates Fatty Streak Formation and Improves High-Density Lipoprotein Cholesterol in the Tfm Mouse: An Effect That Is Independent of the Classic Androgen Receptor Circulation, November 20, 2007; 116(21): 2427 - 2434. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Maggio, F. Lauretani, G. P. Ceda, S. Bandinelli, S. M. Ling, E. J. Metter, A. Artoni, L. Carassale, A. Cazzato, G. Ceresini, et al. Relationship Between Low Levels of Anabolic Hormones and 6-Year Mortality in Older Men: The Aging in the Chianti Area (InCHIANTI) Study Arch Intern Med, November 12, 2007; 167(20): 2249 - 2254. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. K. Bowles, K. K. Maddali, V. C. Dhulipala, and D. H. Korzick PKC{delta} mediates anti-proliferative, pro-apoptic effects of testosterone on coronary smooth muscle Am J Physiol Cell Physiol, August 1, 2007; 293(2): C805 - C813. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. B. Araujo, V. Kupelian, S. T. Page, D. J. Handelsman, W. J. Bremner, and J. B. McKinlay Sex Steroids and All-Cause and Cause-Specific Mortality in Men Arch Intern Med, June 25, 2007; 167(12): 1252 - 1260. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A Mohr, S. Bhasin, C. L Link, A. B O'Donnell, and J. B McKinlay The effect of changes in adiposity on testosterone levels in older men: longitudinal results from the Massachusetts Male Aging Study Eur. J. Endocrinol., September 1, 2006; 155(3): 443 - 452. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Shores, A. M. Matsumoto, K. L. Sloan, and D. R. Kivlahan Low Serum Testosterone and Mortality in Male Veterans. Arch Intern Med, August 14, 2006; 166(15): 1660 - 1665. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Arnlov, M. J. Pencina, S. Amin, B.-H. Nam, E. J. Benjamin, J. M. Murabito, T. J. Wang, P. E. Knapp, R. B. D'Agostino Sr., S. Bhasin, et al. Endogenous sex hormones and cardiovascular disease incidence in men. Ann Intern Med, August 1, 2006; 145(3): 176 - 184. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D Kapoor, E Goodwin, K S Channer, and T H Jones Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur. J. Endocrinol., June 1, 2006; 154(6): 899 - 906. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. L. Ding, Y. Song, V. S. Malik, and S. Liu Sex Differences of Endogenous Sex Hormones and Risk of Type 2 Diabetes: A Systematic Review and Meta-analysis JAMA, March 15, 2006; 295(11): 1288 - 1299. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. K. Yaggi, A. B. Araujo, and J. B. McKinlay Sleep duration as a risk factor for the development of type 2 diabetes. Diabetes Care, March 1, 2006; 29(3): 657 - 661. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Hougaku, J. L. Fleg, S. S. Najjar, E. G. Lakatta, S. M. Harman, M. R. Blackman, and E. J. Metter Relationship between androgenic hormones and arterial stiffness, based on longitudinal hormone measurements Am J Physiol Endocrinol Metab, February 1, 2006; 290(2): E234 - E242. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. K. Maddali, D. H. Korzick, D. L. Tharp, and D. K. Bowles PKC{delta} Mediates Testosterone-induced Increases in Coronary Smooth Muscle Cav1.2 J. Biol. Chem., December 30, 2005; 280(52): 43024 - 43029. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. S. Ford and S. Liu Invited Commentary: Acne in Adolescence--Protecting the Heart but Damaging the Prostate Later in Life? Am. J. Epidemiol., June 15, 2005; 161(12): 1102 - 1106. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Makinen, M. J. Jarvisalo, P. Pollanen, A. Perheentupa, K. Irjala, M. Koskenvuo, J. Makinen, I. Huhtaniemi, and O. T. Raitakari Increased Carotid Atherosclerosis in Andropausal Middle-Aged Men J. Am. Coll. Cardiol., May 17, 2005; 45(10): 1603 - 1608. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Muller, D. E. Grobbee, I. den Tonkelaar, S. W. J. Lamberts, and Y. T. van der Schouw Endogenous Sex Hormones and Metabolic Syndrome in Aging Men J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2618 - 2623. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Muller, A. W. van den Beld, M. L. Bots, D. E. Grobbee, S. W.J. Lamberts, and Y. T. van der Schouw Endogenous Sex Hormones and Progression of Carotid Atherosclerosis in Elderly Men Circulation, May 4, 2004; 109(17): 2074 - 2079. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. H. Mikulec, L. Holloway, R. E. Krasnow, H. Javitz, G. E. Swan, T. Reed, R. Marcus, and D. Carmelli Relationship of Endogenous Sex Hormones to Coronary Heart Disease: A Twin Study J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1240 - 1245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bhasin, W. E. Taylor, R. Singh, J. Artaza, I. Sinha-Hikim, R. Jasuja, H. Choi, and N. F. Gonzalez-Cadavid The Mechanisms of Androgen Effects on Body Composition: Mesenchymal Pluripotent Cell as the Target of Androgen Action J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2003; 58(12): M1103 - 1110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Muller, Y. T. van der Schouw, J. H. H. Thijssen, and D. E. Grobbee Endogenous Sex Hormones and Cardiovascular Disease in Men J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5076 - 5086. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Callies, H. Stromer, R. H. G. Schwinger, B. Bolck, K. Hu, S. Frantz, A. Leupold, S. Beer, B. Allolio, and A. W. Bonz Administration of Testosterone Is Associated with a Reduced Susceptibility to Myocardial Ischemia Endocrinology, October 1, 2003; 144(10): 4478 - 4483. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Svartberg, R. Jorde, J. Sundsfjord, K. H. Bonaa, and E. Barrett-Connor Seasonal Variation of Testosterone and Waist to Hip Ratio in Men: The Tromso Study J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3099 - 3104. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.J. Malkin, P.J. Pugh, T.H. Jones, and K.S. Channer Testosterone for secondary prevention in men with ischaemic heart disease? QJM, July 1, 2003; 96(7): 521 - 529. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Y. Liu, A. K. Death, and D. J. Handelsman Androgens and Cardiovascular Disease Endocr. Rev., June 1, 2003; 24(3): 313 - 340. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Fukui, Y. Kitagawa, N. Nakamura, M. Kadono, S. Mogami, C. Hirata, N. Ichio, K. Wada, G. Hasegawa, and T. Yoshikawa Association Between Serum Testosterone Concentration and Carotid Atherosclerosis in Men With Type 2 Diabetes Diabetes Care, June 1, 2003; 26(6): 1869 - 1873. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bhasin and K. Herbst Testosterone and Atherosclerosis Progression in Men Diabetes Care, June 1, 2003; 26(6): 1929 - 1931. [Full Text] [PDF]
|
|
|
|
|
|
F. C. W. Wu and A. von Eckardstein Androgens and Coronary Artery Disease Endocr. Rev., April 1, 2003; 24(2): 183 - 217. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Nahrendorf, S. Frantz, K. Hu, C. von zur Muhlen, M. Tomaszewski, H. Scheuermann, R. Kaiser, V. Jazbutyte, S. Beer, W. Bauer, et al. Effect of testosterone on post-myocardial infarction remodeling and function Cardiovasc Res, February 1, 2003; 57(2): 370 - 378. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Hak, J. C. M. Witteman, F. H. de Jong, M. I. Geerlings, A. Hofman, and H. A. P. Pols Low Levels of Endogenous Androgens Increase the Risk of Atherosclerosis in Elderly Men: The Rotterdam Study J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3632 - 3639. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Matsumoto Andropause: Clinical Implications of the Decline in Serum Testosterone Levels With Aging in Men J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2002; 57(2): M76 - 99. [Full Text]
|
|
|
|
 |
|
 G. A. Brown, E. R. Martini, B. S. Roberts, M. D. Vukovich, and D. S. King Acute hormonal response to sublingual androstenediol intake in young men J Appl Physiol, January 1, 2002; 92(1): 142 - 146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. B. Singh, S. Hsia, P. Alaupovic, I. Sinha-Hikim, L. Woodhouse, T. A. Buchanan, R. Shen, R. Bross, N. Berman, and S. Bhasin The Effects of Varying Doses of T on Insulin Sensitivity, Plasma Lipids, Apolipoproteins, and C-Reactive Protein in Healthy Young Men J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 136 - 143. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Smith, S. Bennett, L. M. Evans, H. G. Kynaston, M. Parmar, M. D. Mason, J. R. Cockcroft, M. F. Scanlon, and J. S. Davies The Effects of Induced Hypogonadism on Arterial Stiffness, Body Composition, and Metabolic Parameters in Males with Prostate Cancer J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4261 - 4267. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Caplea, D. Seachrist, G. Dunphy, and D. Ely Sodium-induced rise in blood pressure is suppressed by androgen receptor blockade Am J Physiol Heart Circ Physiol, April 1, 2001; 280(4): H1793 - H1801. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G.M.C. Rosano Androgens and coronary artery disease. A sex-specific effect of sex hormones? Eur. Heart J., June 1, 2000; 21(11): 868 - 871. [PDF]
|
|
|
|
|
|
K.M English, O Mandour, R.P Steeds, M.J Diver, T.H Jones, and K.S Channer Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms Eur. Heart J., June 1, 2000; 21(11): 890 - 894. [Abstract] [PDF]
|
|
|
|
|
|
C. S. Hayward, R. P. Kelly, and P. Collins The roles of gender, the menopause and hormone replacement on cardiovascular function Cardiovasc Res, April 1, 2000; 46(1): 28 - 49. [Full Text] [PDF]
|
|
|
|
|
|
A. M. Isidori, M. Caprio, F. Strollo, C. Moretti, G. Frajese, A. Isidori, and A. Fabbri Leptin and Androgens in Male Obesity: Evidence for Leptin Contribution to Reduced Androgen Levels J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3673 - 3680. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Arlt, J. Haas, F. Callies, M. Reincke, D. Hübler, M. Oettel, M. Ernst, H. M. Schulte, and B. Allolio Biotransformation of Oral Dehydroepiandrosterone in Elderly Men: Significant Increase in Circulating Estrogens J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2170 - 2176. [Abstract] [Full Text]
|
|
|
|
|
|
J. A. McCrohon, W. Jessup, D. J. Handelsman, and D. S. Celermajer Androgen Exposure Increases Human Monocyte Adhesion to Vascular Endothelium and Endothelial Cell Expression of Vascular Cell Adhesion Molecule-1 Circulation, May 4, 1999; 99(17): 2317 - 2322. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Alexandersen, J. Haarbo, I. Byrjalsen, H. Lawaetz, and C. Christiansen Natural Androgens Inhibit Male Atherosclerosis : A Study in Castrated, Cholesterol-Fed Rabbits Circ. Res., April 16, 1999; 84(7): 813 - 819. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Barrett-Connor Sex Differences in Coronary Heart Disease: Why Are Women So Superior? The 1995 Ancel Keys Lecture Circulation, January 7, 1997; 95(1): 252 - 264. [Full Text]
|
|
|
|
 |
|
 L. L. Jeppesen, H. S. Jorgensen, H. Nakayama, H. O. Raaschou, T. S. Olsen, and K. Winther Decreased Serum Testosterone in Men With Acute Ischemic Stroke Arterioscler. Thromb. Vasc. Biol., June 1, 1996; 16(6): 749 - 754. [Abstract] [Full Text]
|
|
|
|
|
|
M. R. Adams, J. K. Williams, and J. R. Kaplan Effects of Androgens on Coronary Artery Atherosclerosis and Atherosclerosis-Related Impairment of Vascular Responsiveness Arterioscler. Thromb. Vasc. Biol., May 1, 1995; 15(5): 562 - 570. [Abstract] [Full Text]
|
|